ATTO-003

N/A

Report date: 2024/11/14 14:17:39

Base Information

Drug NameATTO-003
Drug Alias NameATTO-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-V-set domain-containing T-cell activation inhibitor 1
TargetsV-set domain-containing T-cell activation inhibitor 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAttovia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAttovia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A